// App-Quantinova.ai

: Novel BAFF-R CAR T-Cell Therapy for CD19 Antigen-Loss Relapsed B Cell Tumors

Researchers

Presenter

  • Hong Qin

Principal Investigators

  • Zhenyuan Dong

  • Xiuli Wang

  • Wesley Cheng

  • Diane Lynne Smith

  • Joo Y Song

  • Ibrahim Aldoss

  • Markus Muschen

  • Stephen J Forman

  • Larry W Kwak

Medical Centers

  • Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of the City of Hope, City of Hope National Medical Center, Duarte, CA

  • Center for CAR T Cell Therapy, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA

  • Department of pathology, City of Hope National Medical Center, Duarte, CA.

  • Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

  • Department of Systems Biology,Beckman Research Institute,City of Hope,États-unis

  • Department of Hematology/HCT, City of Hope, Duarte, CA

  • Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Interferon-gamma

  • Translocator protein

Drug/Treatment

  • Blinatumomab

  • Interferon Gamma

  • IFN-lambda

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A